为您找到相关结果约90个

你是不是要搜索 期刊Rezafungin 点击跳转

EUCAST Reference Testing of Rezafungin Susceptibility and Impact of Choice of Plastic Plates

Efficacy of Rezafungin in Prophylactic Mouse Models of Invasive Candidiasis, Aspergillosis, and Pneumocystis

Multicentre determination of rezafungin (CD101) susceptibility of Candida species by the EUCAST method

Rezafungin prophylactic efficacy in a mouse model of pneumocystis pneumonia

Rezafungin and invasive candida infections: a new game changing antifungal?

Coadministration of rezafungin does not impact cyclosporine or mycophenolate mofetil pharmacokinetics

ONCE-WEEKLY REZAFUNGIN VERSUS DAILY CASPOFUNGIN TREATMENT OF CANDIDEMIA/ INVASIVE CANDIDIASIS

Pharmacodynamic Evaluation of Rezafungin (CD101) against Candida auris in the Neutropenic Mouse Invasive

Rezafungin (CD101), a next-generation echinocandin: A systematic literature review and assessment of

EFFECT OF MODERATE HEPATIC IMPAIRMENT ON THE SAFETY AND PHARMACOKINETICS OF REZAFUNGIN

Overcoming the Resistance Hurdle: Pharmacokinetic-Pharmacodynamic Target Attainment Analyses for Rezafungin

Rezafungin (CD101) demonstrates potent in vitro activity against Aspergillus, including azole-resistant

Candida infection: epidemiology, clinical and therapeutic aspects of an evolving disease and the role of rezafungin

Growth and Trailing Effect with Caspofungin, Micafungin, Anidulafungin, and the Novel Echinocandin Rezafungin

Population pharmacokinetic modeling and target attainment analyses of rezafungin for the treatment of

为您找到相关结果约90个

共90条页码: 2/6页15条/页